Cargando…

HBD3 Induces PD-L1 Expression on Head and Neck Squamous Cell Carcinoma Cell Lines

Human β-defensin 3 (HBD3) is an antimicrobial peptide up-regulated in the oral tissues of individuals with head and neck squamous cell carcinomas (HNSCC) and oral squamous cell carcinomas (SCC) and present in high concentrations in their saliva. In this study, we determined if HBD3 contributes to HN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez Hernandez, Maria Paula, Bates, Amber M., Starman, Emily E., Lanzel, Emily A., Comnick, Carissa, Xie, Xian Jin, Brogden, Kim A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963492/ https://www.ncbi.nlm.nih.gov/pubmed/31554151 http://dx.doi.org/10.3390/antibiotics8040161

Ejemplares similares

A distinguishing profile of chemokines, cytokines and biomarkers in the saliva of children with Sjögren’s syndrome
por: Gomez Hernandez, M Paula, et al.
Publicado: (2021)

Dataset-chemokines, cytokines, and biomarkers in the saliva of children with Sjögren's syndrome
por: Withanage, Miyuraj Harishchandra Hikkaduwa, et al.
Publicado: (2021)

Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer
por: Fischer, Carol L., et al.
Publicado: (2019)

Tissue-specific human beta-defensins (HBD)1, HBD2, and HBD3 secretion from human extra-placental membranes stimulated with Escherichia coli
por: Garcia-Lopez, Guadalupe, et al.
Publicado: (2010)

Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19
por: Brancaccio, Mariarita, et al.
Publicado: (2022)

Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma
por: Rasmussen, Jacob H., et al.
Publicado: (2019)

Differential cytotoxicity of long-chain bases for human oral gingival epithelial keratinocytes, oral fibroblasts, and dendritic cells
por: Mehalick, Leslie A., et al.
Publicado: (2015)

PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)

Oxygen Deprivation Modulates EGFR and PD-L1 in Squamous Cell Carcinomas of the Head and Neck
por: Zahnreich, Sebastian, et al.
Publicado: (2021)

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
por: Zandberg, Dan P, et al.
Publicado: (2021)

Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
por: Ribbat-Idel, Julika, et al.
Publicado: (2021)

Systematic review and meta-analysis of oral squamous cell carcinoma associated oral microbiome
por: Peter, Tabitha K., et al.
Publicado: (2022)

hBD-2 is downregulated in oral carcinoma cells by DNA hypermethylation, and increased expression of hBD-2 by DNA demethylation and gene transfection inhibits cell proliferation and invasion
por: KAMINO, YOSHITAKA, et al.
Publicado: (2014)

Nuclear Localization of HBD-1 in Human Keratinocytes
por: Bick, Roger J., et al.
Publicado: (2007)

Tissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture system
por: Zaga-Clavellina, Veronica, et al.
Publicado: (2012)

Spatial Profiles of Intratumoral PD-1(+) Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
por: Yoshimura, Kanako, et al.
Publicado: (2021)

Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma
por: Schulz, Daniela, et al.
Publicado: (2021)

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
por: Young, Natalie R., et al.
Publicado: (2015)

Cytotoxic Effect of Thiabendazole on Hn5 Head and Neck Squamous Cell Carcinoma Cell Line
por: Abassi, Amir Jalal, et al.
Publicado: (2017)

Effect of ethanol extracts of Antrodia cinnamomea on head and neck squamous cell carcinoma cell line
por: Liu, Li, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma
por: de Medeiros, Marcell Costa, et al.
Publicado: (2022)

Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.
por: Easty, D. M., et al.
Publicado: (1981)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma
por: Shen, Bin, et al.
Publicado: (2019)

PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinoma
por: Evrard, D., et al.
Publicado: (2020)

Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
por: Puladi, Behrus, et al.
Publicado: (2021)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
por: Callejas-Valera, Juan L., et al.
Publicado: (2022)

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023)

Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue
por: Stebe-Frick, Sabrina, et al.
Publicado: (2018)

Oral Microbiome Community Composition in Head and Neck Squamous Cell Carcinoma
por: Benjamin, William J., et al.
Publicado: (2023)

Human beta defensin (HBD) gene copy number affects HBD2 protein levels: impact on cervical bactericidal immunity in pregnancy
por: James, Catherine P., et al.
Publicado: (2018)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
por: Lee, Yunqin, et al.
Publicado: (2014)

PD-L1 promotes head and neck squamous cell carcinoma cell growth through mTOR signaling
por: Zheng, Anyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gsl78r5n87ktbfc7n7g8i9rpcv